Search

everythinglearnresearchcommunity

for

Search:↓

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Early onset hair loss linked to genetics and androgen levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Overweight women with PCOS are more likely to have excess male hormones.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

The side gland of Suncus murinus is a good model for studying human sebaceous glands.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.